SODIUM CHLORIDE, Truxima 500 mg concentrate for solution for infusion
APHP240909
Phase 3 small_molecule active
Quick answer
SODIUM CHLORIDE, Truxima 500 mg concentrate for solution for infusion for Patient with stabilized SSc-ILD (as defined by a decline of FVC ≤ 5%) following RTX induction treatment is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Patient with stabilized SSc-ILD (as defined by a decline of FVC ≤ 5%) following RTX induction treatment
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active